Course Director

Phillip D. Levy, MD, MPH, FACEP, FAHA, FACC
Phillip D. Levy, MD, MPH, FACEP, FAHA, FACC

Wayne State University
Detroit, Michigan

Accredited by

American College of Emergency Physicians

Activity Details

Credit Types:CME
Credit Amount:1.0 Credits
Release Date:2017-Mar-28
Expiration Date:2018-Mar-27
Estimated Time for Completion:1 hour
Registration Required:No
Cost:Free of charge
Activity Description and Educational Objectives
In this activity, an expert in hyperkalemia discusses best practices for the diagnosis and management of hyperkalemia and how the integration of evidence-based treatment options and care can lead to improved outcomes for patients with hyperkalemia.

Upon completion of this activity, participants should be better able to:
  • Recognize the burden of hyperkalemia in patients with heart failure and chronic kidney disease
  • Assess at-risk patients appropriately for clinical manifestations of hyperkalemia to diagnose them in a timely manner
  • Discuss recent data and clinical utility of novel agents for the management of various patient populations with hyperkalemia
  • Employ evidence-based, individualized treatment strategies in patients with mild, moderate, and severe hyperkalemia, taking into account patient/disease characteristics and mechanisms of action, benefits, and risks of available therapies
  • Apply evidence-based strategies for transitioning care from emergency physicians to hospitalists to improve outcomes in patients with hyperkalemia
Target Audience
This activity has been designed to meet the educational needs of emergency medicine physicians, hospitalists, and other clinicians involved in treating patients with hyperkalemia.

Requirements for Successful Completion
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. Participants must get 80% correct to pass the post-test. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: March 28, 2017 - March 27, 2018
Time to Complete: 60 minutes

Faculty & Disclosure / Conflict of Interest Policy
In accordance with ACCME requirements, the American College of Emergency Physicians has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director
Phillip D. Levy, MD, MPH, FACEP, FAHA, FACC
Professor and Associate Chair for Research
Department of Emergency Medicine
Assistant Vice President for Translational Science and Clinical Research Innovation
Wayne State University
Detroit, Michigan

Phillip D. Levy, MD, MPH, FACEP, FAHA, FACC, has a financial interest/relationship or affiliation in the form of:
Consultant for Cardiorentis AG; Novartis Pharmaceuticals Corporation; Roche Diagnostics, North America; Siemens Medical Solutions USA, Inc.; Trevena, Inc.; and ZS Pharma, Inc.
Grant/Research Support from Bristol-Myers Squibb; Cardiorentis AG; Novartis Pharmaceuticals Corporation; and Trevena, Inc.
Shareholder in Mespere LifeSciences Inc.

Medical Director
Chris Washburn, PhD
PVI, PeerView Institute for Medical Education

Chris Washburn, PhD, has no financial interests/relationships or affiliations in relation to this activity.

Providership, Credit & Support
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Emergency Physicians and PVI, PeerView Institute for Medical Education. The American College of Emergency Physicians is accredited by the ACCME to provide continuing medical education for physicians.

The American College of Emergency Physicians designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CME activity is jointly provided by the American College of Emergency Physicians and PVI, PeerView Institute for Medical Education.

This activity is supported by an educational grant from ZS Pharma, Inc., a member of the AstraZeneca Group.

Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its partners, providers, and/or supporters.

Copyright © 2000-2017, PeerView Press - Medical Education Resource

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.